NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common heart drug may shield eyes of type 1 diabetes patients
Disease control OngoingThis study tests whether fenofibrate, a drug typically used to lower blood fats, can slow the worsening of diabetic retinopathy (eye damage) in adults with type 1 diabetes. Over 400 participants take either fenofibrate or a placebo daily for three years. The goal is to see if the…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cheap pill could save millions from blindness, major trial launches
Prevention OngoingThis study tests whether fenofibrate, a drug already used for high cholesterol, can prevent diabetic retinopathy from worsening in people with mild to moderate disease. About 560 adults with diabetes will take either fenofibrate or a placebo for up to 6 years. The goal is to see …
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC